106 related articles for article (PubMed ID: 15919085)
1. SSTR5 ablation in islet results in alterations in glucose homeostasis in mice.
Wang XP; Yang J; Norman MA; Magnusson J; DeMayo FJ; Brunicardi FC
FEBS Lett; 2005 Jun; 579(14):3107-14. PubMed ID: 15919085
[TBL] [Abstract][Full Text] [Related]
2. The effect of global SSTR5 gene ablation on the endocrine pancreas and glucose regulation in aging mice.
Wang XP; Norman M; Yang J; Liu SH; Magnusson J; DeMayo FJ; Brunicardi FC
J Surg Res; 2005 Nov; 129(1):64-72. PubMed ID: 16026801
[TBL] [Abstract][Full Text] [Related]
3. Double-gene ablation of SSTR1 and SSTR5 results in hyperinsulinemia and improved glucose tolerance in mice.
Wang XP; Norman MA; Yang J; Cheung A; Moldovan S; Demayo FJ; Brunicardi FC
Surgery; 2004 Sep; 136(3):585-92. PubMed ID: 15349106
[TBL] [Abstract][Full Text] [Related]
4. Alterations in glucose homeostasis in SSTR1 gene-ablated mice.
Wang XP; Norman M; Yang J; Magnusson J; Kreienkamp HJ; Richter D; DeMayo FJ; Brunicardi FC
Mol Cell Endocrinol; 2006 Mar; 247(1-2):82-90. PubMed ID: 16406265
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin receptor subtype 5 regulates insulin secretion and glucose homeostasis.
Strowski MZ; Kohler M; Chen HY; Trumbauer ME; Li Z; Szalkowski D; Gopal-Truter S; Fisher JK; Schaeffer JM; Blake AD; Zhang BB; Wilkinson HA
Mol Endocrinol; 2003 Jan; 17(1):93-106. PubMed ID: 12511609
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic somatostatin inhibits insulin secretion via SSTR-5 in the isolated perfused mouse pancreas model.
Tirone TA; Norman MA; Moldovan S; DeMayo FJ; Wang XP; Brunicardi FC
Pancreas; 2003 Apr; 26(3):e67-73. PubMed ID: 12657967
[TBL] [Abstract][Full Text] [Related]
7. Sulfonylurea receptor knockout causes glucose intolerance in mice that is not alleviated by concomitant somatostatin subtype receptor 5 knockout.
Norman M; Moldovan S; Seghers V; Wang XP; DeMayo FJ; Brunicardi FC
Ann Surg; 2002 Jun; 235(6):767-74. PubMed ID: 12035032
[TBL] [Abstract][Full Text] [Related]
8. Negative regulation of pancreatic and duodenal homeobox-1 by somatostatin receptor subtype 5.
Zhou G; Liu SH; Shahi KM; Wang H; Duan X; Lin X; Feng XH; Li M; Fisher WE; Demayo FJ; Dawson D; Brunicardi FC
Mol Endocrinol; 2012 Jul; 26(7):1225-34. PubMed ID: 22669743
[TBL] [Abstract][Full Text] [Related]
9. Somatostatin inhibits insulin and glucagon secretion via two receptors subtypes: an in vitro study of pancreatic islets from somatostatin receptor 2 knockout mice.
Strowski MZ; Parmar RM; Blake AD; Schaeffer JM
Endocrinology; 2000 Jan; 141(1):111-7. PubMed ID: 10614629
[TBL] [Abstract][Full Text] [Related]
10. Regulation of Endogenous (Male) Rodent GLP-1 Secretion and Human Islet Insulin Secretion by Antagonism of Somatostatin Receptor 5.
Farb TB; Adeva M; Beauchamp TJ; Cabrera O; Coates DA; Meredith TD; Droz BA; Efanov A; Ficorilli JV; Gackenheimer SL; Martinez-Grau MA; Molero V; Ruano G; Statnick MA; Suter TM; Syed SK; Toledo MA; Willard FS; Zhou X; Bokvist KB; Barrett DG
Endocrinology; 2017 Nov; 158(11):3859-3873. PubMed ID: 28938487
[TBL] [Abstract][Full Text] [Related]
11. Insulin secretion is inhibited by subtype five somatostatin receptor in the mouse.
Fagan SP; Azizzadeh A; Moldovan S; Ray MK; Adrian TE; Ding X; Coy DH; Brunicardi FC
Surgery; 1998 Aug; 124(2):254-8; discussion 258-9. PubMed ID: 9706146
[TBL] [Abstract][Full Text] [Related]
12. Characterization of somatostatin receptor subtype-specific regulation of insulin and glucagon secretion: an in vitro study on isolated human pancreatic islets.
Singh V; Brendel MD; Zacharias S; Mergler S; Jahr H; Wiedenmann B; Bretzel RG; Plöckinger U; Strowski MZ
J Clin Endocrinol Metab; 2007 Feb; 92(2):673-80. PubMed ID: 17105845
[TBL] [Abstract][Full Text] [Related]
13. Deficiency of somatostatin (SST) receptor type 5 (SSTR5) is associated with sexually dimorphic changes in the expression of SST and SST receptors in brain and pancreas.
Ramírez JL; Grant M; Norman M; Wang XP; Moldovan S; de Mayo FJ; Brunicardi C; Kumar U
Mol Cell Endocrinol; 2004 Jun; 221(1-2):105-19. PubMed ID: 15223137
[TBL] [Abstract][Full Text] [Related]
14. Ablation of somatostatin cells leads to impaired pancreatic islet function and neonatal death in rodents.
Li N; Yang Z; Li Q; Yu Z; Chen X; Li JC; Li B; Ning SL; Cui M; Sun JP; Yu X
Cell Death Dis; 2018 Jun; 9(6):682. PubMed ID: 29880854
[TBL] [Abstract][Full Text] [Related]
15. Microarray analysis of somatostatin receptor 5-regulated gene expression profiles in murine pancreas.
Patel SG; Zhou G; Liu SH; Li M; Jeong JW; DeMayo FJ; Gingras MC; Gibbs RA; Fisher WE; Brunicardi FC
World J Surg; 2009 Apr; 33(4):630-7. PubMed ID: 19137362
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin inhibits insulin release via SSTR2 in hamster clonal beta-cells and pancreatic islets.
Yao CY; Gill M; Martens CA; Coy DH; Hsu WH
Regul Pept; 2005 Jul; 129(1-3):79-84. PubMed ID: 15927701
[TBL] [Abstract][Full Text] [Related]
17. The role of voltage-gated potassium channels Kv2.1 and Kv2.2 in the regulation of insulin and somatostatin release from pancreatic islets.
Li XN; Herrington J; Petrov A; Ge L; Eiermann G; Xiong Y; Jensen MV; Hohmeier HE; Newgard CB; Garcia ML; Wagner M; Zhang BB; Thornberry NA; Howard AD; Kaczorowski GJ; Zhou YP
J Pharmacol Exp Ther; 2013 Feb; 344(2):407-16. PubMed ID: 23161216
[TBL] [Abstract][Full Text] [Related]
18. Beta-cell-specific ablation of the hepatocyte growth factor receptor results in reduced islet size, impaired insulin secretion, and glucose intolerance.
Dai C; Huh CG; Thorgeirsson SS; Liu Y
Am J Pathol; 2005 Aug; 167(2):429-36. PubMed ID: 16049329
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic deletion of insulin receptor substrate 2 reduces beta and alpha cell mass and impairs glucose homeostasis in mice.
Cantley J; Choudhury AI; Asare-Anane H; Selman C; Lingard S; Heffron H; Herrera P; Persaud SJ; Withers DJ
Diabetologia; 2007 Jun; 50(6):1248-56. PubMed ID: 17393136
[TBL] [Abstract][Full Text] [Related]
20. Constitutively active stimulatory G-protein alpha s in beta-cells of transgenic mice causes counterregulation of the increased adenosine 3',5'-monophosphate and insulin secretion.
Ma YH; Landis C; Tchao N; Wang J; Rodd G; Hanahan D; Bourne HR; Grodsky GM
Endocrinology; 1994 Jan; 134(1):42-7. PubMed ID: 7506212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
